| Name | Title | Contact Details |
|---|
Founded in 2011, Invictus Medical is a privately owned Delaware “C” Corporation with headquarters in San Antonio, Texas. Currently, we are in the latter stages of developing our award-winning cranial support technology into our first product for commercialization. To secure early healthy development in newborns by providing innovative products, services, and solutions to the healthcare professional and consumer markets. Invictus Medical is committed to providing safe and effective medical products and high levels of service to the healthcare and consumer markets.
TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular`s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular`s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.
Body Mechanics is a Allston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aspen Seating is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.